| CL1894A |
|
1025687-58-4 |
(6-((5-氟-2-((3,4,5-三甲氧基苯基)氨基)嘧啶-4-基)氨基)-2,2-二甲基-3-氧代-2H-吡啶并[3,2-b][1,4]惡嗪-4(3H)-基)甲基磷酸鈉；福他替尼二鈉鹽
Fostamatinib Disodium;R788 Disodium
-
98+%
|
需詢價(jià) |
C23H24FN6Na2O9P |
|
|
|
| CLP1144 |
|
1401708-83-5 |
N-((S)-1-(((2S,3S)-1-((6-氨基-6-氧代己基)氨基)-3-甲基-1-氧代戊烷-2-基)氨基)-3-(4-羥基苯基)-1-氧代丙烷-2-基)己酰胺 ;益智二肽
Dihexa (Synonyms: PNB-0408; N-hexanoic-Try-Ile-(6)-amino hexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2)
-
98+%
|
需詢價(jià) |
C27H44N4O5 |
|
|
|
| CL3145 |
|
257933-82-7 |
(E)-N-[4-[(3-氯-4-氟苯基)氨基]-3-氰基-7-乙氧基-6-喹啉基]-4-(二甲基氨基)-2-丁烯酰胺; 培利替尼; 貝利替尼
Pelitinib (Synonyms: EKB-569; WAY-EKB 569)
-
98+%
|
需詢價(jià) |
C24H23ClFN5O2 |
|
|
|
| CL3126 |
|
1707289-21-1 |
N-((3S,4S)-3-((6-(2,6-二氯-3,5-二甲氧基苯基)喹唑啉-2-基)氨基)四氫-2H-吡喃-4-基)丙烯酰胺
Fisogatinib (Synonyms: BLU-554)
3-5 days
98+%
|
￥316.00 |
C24H24Cl2N4O4 |
|
|
|
| CL3117 |
|
1513857-77-6 |
3-(2,6-二氟-3,5-二甲氧基苯基)-1-乙基-8-(嗎啉代甲基)-1,3,4,6-四氫-2H-吡咯并[3',2':5,6]吡啶并[4,3-d]嘧啶-2-酮 ；培米加替尼；培米替尼
Pemigatinib (Synonyms: INCB054828)
3-5 days
99+%
|
￥356.00 |
C24H27F2N5O4 |
|
|
|
| CL1632A |
|
439081-18-2 |
(S)-N-(4-((3-氯-4-氟苯基)氨基(S)-N-(4-((3-四氫呋喃-3-基)氧基)喹唑啉-6-基)-4-(二甲基氨基)丁-2-烯酰胺
(E/Z)-Afatinib (Synonyms: (E/Z)-BIBW 2992; （S)-阿法替尼)
-
98+%
|
需詢價(jià) |
C24H25ClFN5O3 |
|
|
|
| CL3105 |
|
1303420-67-8 |
6-氟-N-((5-氟-2-甲氧基吡啶-3-基)甲基)-5-((5-甲基-1H-吡咯并[2,3-b]吡啶-3-基)甲基)吡啶 -2-胺;PLX5622
PLX5622
3-5 days
98+%
|
￥366.00 |
C21H19F2N5O |
|
|
|
| CL3084 |
|
761439-42-3 |
NVP-TAE 684 | TAE 684
NVP-TAE 684 | TAE 684
-
98+%
|
需詢價(jià) |
C30H40ClN7O3S |
|
|
|
| CL3074 |
|
928037-13-2 |
Golvatinib | E-7050
Golvatinib | E-7050
3-5days
98+%
|
￥288.00 |
C33H37F2N7O4 |
|
|
|
| CL2211A |
|
1421373-66-1 |
邁瑞替尼甲磺酸鹽 | 奧希替尼甲磺酸鹽
AZD-9291 mesylate | Osimertinib mesylate | Mereletinib mesylate
-
98+%
|
需詢價(jià) |
C29H37N7O5S |
|
|
|
| CLA1682 |
|
1826843-81-5 |
德喜曲妥珠單抗 | 德盧替康-曲妥珠單抗
Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd)
-
98+%
|
需詢價(jià) |
— |
|
|
|
| CL2990 |
|
670220-88-9 |
克萊拉尼
Crenolanib | CP-868596 | ARO 002
3-5days
98+%
|
￥306.00 |
C26H29N5O2 |
|
|
|
| CL1991A |
|
252003-71-7 |
CP-547632 HCl
CP-547632 hydrochloride
-
98+%
|
需詢價(jià) |
C20H24BrF2N5O3S·HCl |
|
|
|
| CL2953A |
|
1702864-11-6 |
FF-10101 succinate
FF-10101 succinate
-
98+%
|
需詢價(jià) |
C33H44N8O6 |
|
|
|
| CL2954 |
|
1370256-78-2 |
SKLB4771 | FLT3-IN-1
SKLB4771 | FLT3-IN-1
3-5days
98+%
|
￥866.00 |
C25H27N7O3S2 |
|
|
|
| CL2953 |
|
1472797-69-5 |
FF-10101 | 酪氨酸蛋白激酶受體 FLT3 抑制劑
FF-10101
3-5days
98+%
|
￥486.00 |
C29H38N8O2 |
|
|
|
| CL2895 |
|
937263-43-9 |
妥卡替尼 | 圖卡替尼
Tucatinib | Irbinitinib | ARRY-380 | ONT-380
3-5days
99+%
|
￥436.00 |
C26H24N8O2 |
|
|
|
| CL2888 |
|
905854-02-6 |
(3R,4R) 替凡替尼 (ARQ 197), 肝細(xì)胞生長因子受體抑制劑 | 替萬替尼
Tivantinib | ARQ-197
-
98+%
|
需詢價(jià) |
C23H19N3O2 |
|
|
|
| CL2879 |
|
252916-29-3 |
奧蘭替尼 | SU 6668 | TSU-68
Orantinib | SU 6668 | TSU-68
-
98+%
|
需詢價(jià) |
C18H18N2O3 |
|
|
|
| CL2840 |
|
1353552-97-2 |
波塞替尼 | HM71224 | LY3337641 | 酪氨酸蛋白激酶 BTK 抑制劑
Poseltinib | HM71224 | LY3337641
3-5days
98+%
|
￥898.00 |
C26H26N6O3 |
|
|
|
